EUROIMMUN US Academy - Antigen - How can therapeutic drug monitoring be used to optimize inflammatory bowel disease treatment?

Antigen Content | Therapeutic Drug Monitoring

How can therapeutic drug monitoring be used to optimize inflammatory bowel disease treatment?

Presented on: 7/13/2023
Abstract

Therapeutic drug monitoring (TDM) plays a critical role in maximizing the benefits of biologic and biosimilar therapy for the treatment of inflammatory bowel disease (IBD). TDM involves measuring blood drug concentrations and detecting anti-drug antibodies (ADAs) to ensure the effectiveness of the therapy and make necessary adjustments when required. In this webinar, Dr. Michael J Rosen, pediatric gastroenterologist from Stanford University, provides an update on TDM for IBD and discusses the strengths and limitations of therapeutic drug monitoring for IBD.

Speakers

Michael J Rosen, MD, MSCI
Stanford University Endowed Professor for Pediatric IBD and Celiac disease
Director, Center for Pediatric IBD and Celiac Disease

How can therapeutic drug monitoring be used to optimize inflammatory bowel disease treatment?

To view this webinar, please complete the following form.